Coronary collateral circulation in sleep apnea: A cardioprotective mechanism?

Chest

Volumn 137, Issue 3, 2010, Pages 511-512

  Lavie, Lena ^a   Lavie, Peretz ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; VASCULOTROPIN;

AGING; CLINICAL FEATURE; CORONARY ARTERY COLLATERAL CIRCULATION; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; MORBIDITY; MORTALITY; MULTICHANNEL RECORDER; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SURVIVAL RATE; UPREGULATION; VASCULARIZATION;

EID: 77949523497     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2657     Document Type: Editorial

References (12)

1. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J. 2009;33(6):1467-1484.
2. Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J. 2005;25(3):514-520.
3. Lavie P, Lavie L. Unexpected survival advantage in elderly people with moderate sleep apnoea. J Sleep Res. 2009;18(4): 397-403.
4. Lavie L, Lavie P. Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Med Hypotheses. 2006;66(6):1069-1073.
5. Lavie L, Kraiczi H, Hefetz A, et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med. 2002;165(12):1624-1628.
6. Schultz A, Lavie L, Hochberg I, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation. 1999;100(5):547-552.
7. Steiner S, Scheller PO, Schulze V, et al. Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion. Chest. 2010;137(3):516-520.
8. Koerselman J, de Jaegere PP, Verhaar MC, van der Graaf Y, Grobbee DE; SMART Study Group. High blood pressure is inversely related with the presence and extent of coronary collaterals. J Hum Hypertens. 2005;19(10):809-817.
9. Resar JR, Roguin A, Voner J, et al. Hypoxia-inducible factor 1alpha polymorphism and coronary collaterals in patients with ischemic heart disease. Chest. 2005;128(2):787-791.
10. Cai Z, Manalo DJ, Wei G, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation. 2003;108(1):79-85.
11. Béguin PC, Belaidi E, Godin-Ribuot D, Lévy P, Ribuot C. Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and Erk1/2. J Mol Cell Cardiol. 2007;42(2):343-351.
12. Naghshin J, McGaffin KR, Witham WG, et al. Chronic intermittent hypoxia increases left ventricular contractility in C57BL/6J mice. J Appl Physiol. 2009;107(3):787-793.